Similar neurocognitive patterns in patients treated with lenalidomide: chemobrain effect?

Conclusions: Lenalidomide treatments can determine severe cognitive impairments especially in elderly patients. Our data suggest the need for a careful evaluation of cognitive decline risk before and after drug administration. However, larger studies are required to confirm our findings. PMID: 31522586 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31522586?dopt=Abstract

Source: Neurocase - September 14, 2019 Category: Neurology Authors: Calvi E, Marchetti M, Santagata F, Luppi C, Coppo E, Massaia M, Isaia GC Tags: Neurocase Source Type: research